Non-PVC IV Bags Market Report by Material (Ethylene Vinyl Acetate, Copolyester-ether, Polypropylene, and Others), Product (Multi Chamber, Single Chamber), Content (Frozen Mixture, Liquid Mixture), Application (Chemotherapy, Targeted Drug Delivery, Glucose

Non-PVC IV Bags Market Report by Material (Ethylene Vinyl Acetate, Copolyester-ether, Polypropylene, and Others), Product (Multi Chamber, Single Chamber), Content (Frozen Mixture, Liquid Mixture), Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Others), End User (Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, and Others), and Region 2024-2032

The global non-PVC IV bags market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.

Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are manufactured using polypropylene, polyethylene, copolyester-ether, and ethylene-vinyl acetate films. They are specifically designed for packaging rehydration solutions and storing certain antibiotics and analgesics for hospital and veterinary usage. Moreover, they can be extensively utilized in cold storage without inhibiting the quality and shelf-life of the stored items. Unlike PVC IV bags that often face drug and container interaction problems, these bags provide improved safety, lowered risks of contamination and enhanced convenience of usage. As a result, non-PVC IV bags find extensive applications in parenteral nutrition, oncology, chemotherapy, and targeted drug deliveries.

Non-PVC IV Bags Market Trends:
The market is primarily driven by the rising incidences of hospital-acquired infections (HAIs) among the masses. Coupled with the increasing influx of patients requiring intravenous antibiotics across healthcare facilities, this has provided a boost to the uptake of non-PVC IV bags. Also, the widespread adoption of single-chambered non-PVC IV bags in IV drips and other mixtures due to their convenience of management, transportation, and disposal is significantly contributing to the product sales. In addition to this, the growing number of point-of-care (POC) facilities across the globe and the preference for home care setups, especially for the geriatric population, are favorably impacting the market growth. The market is further driven by the escalating popularity of IV bags made up of ethylene-vinyl acetate (EVA). Since these bags offer excellent adhesion to non-porous substrates at an affordable price point, they are widely utilized by healthcare professionals on the global level. Some of the other factors creating a positive outlook for the market include the augmenting demand for biologically inert medical supplies, considerable developments in the healthcare infrastructure and extensive research and development (R&D) activities.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global non-PVC IV bags market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on material, product, content, application and end user.

Breakup by Material:

Ethylene Vinyl Acetate
Copolyester-ether
Polypropylene
Others

Breakup by Product:

Multi Chamber
Single Chamber

Breakup by Content:

Frozen Mixture
Liquid Mixture

Breakup by Application:

Chemotherapy
Targeted Drug Delivery
Glucose Injection
Sodium Chloride Solution
Electrolyte Injection
Nutrient Injection
Others

Breakup by End User:

Hospitals
Clinics
Emergency Service Centers
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius SE & Co. KGaA, JW Life Science Co. Ltd., Kraton Corporation (DL Chemical Co. Ltd.), Medline Industries LP, Persico S.p.a., Sealed Air Corporation and Sippex IV bags.

Key Questions Answered in This Report

1. What was the size of the global non-PVC IV bags market in 2023?
2. What is the expected growth rate of the global non-PVC IV bags market during 2024-2032?
3. What are the key factors driving the global non-PVC IV bags market?
4. What has been the impact of COVID-19 on the global non-PVC IV bags market?
5. What is the breakup of the global non-PVC IV bags market based on the material?
6. What is the breakup of the global non-PVC IV bags market based on the product?
7. What is the breakup of the global non-PVC IV bags market based on content?
8. What is the breakup of the global non-PVC IV bags market based on the end user?
9. What are the key regions in the global non-PVC IV bags market?
10. Who are the key players/companies in the global non-PVC IV bags market?